Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Timothy Ashby

Concepts (199)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
38
2024
2998
2.740
Why?
High-Throughput Nucleotide Sequencing
7
2022
169
1.170
Why?
Genomics
10
2023
279
0.860
Why?
Mutation
14
2022
1280
0.860
Why?
Software
4
2021
276
0.850
Why?
Tumor Microenvironment
4
2024
222
0.610
Why?
Clonal Evolution
4
2020
56
0.580
Why?
Plasma Cells
6
2023
221
0.570
Why?
Computational Biology
4
2020
215
0.540
Why?
Gene Expression Regulation, Neoplastic
6
2024
833
0.520
Why?
Algorithms
4
2020
625
0.500
Why?
Neoplasm Recurrence, Local
5
2024
629
0.460
Why?
Monoclonal Gammopathy of Undetermined Significance
3
2024
112
0.450
Why?
Translocation, Genetic
7
2022
240
0.400
Why?
Neoplasms
2
2020
1251
0.400
Why?
Humans
46
2024
50503
0.400
Why?
Hematopoietic Stem Cell Transplantation
3
2024
578
0.390
Why?
Osteolysis
2
2022
74
0.380
Why?
Models, Molecular
1
2013
334
0.380
Why?
Chromosome Aberrations
3
2023
280
0.360
Why?
Gene Expression Profiling
9
2023
1025
0.360
Why?
Genome, Human
3
2021
109
0.360
Why?
Evolution, Molecular
2
2021
95
0.350
Why?
Osteocytes
2
2024
224
0.350
Why?
Signal Transduction
4
2024
1624
0.340
Why?
Proteins
1
2013
339
0.340
Why?
Prognosis
11
2024
1978
0.330
Why?
Bone Marrow
3
2020
363
0.320
Why?
Epigenomics
2
2021
68
0.310
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
1000
0.270
Why?
RANK Ligand
2
2024
187
0.260
Why?
Disease Progression
7
2023
829
0.240
Why?
Gene Rearrangement
2
2023
65
0.240
Why?
Oncogenes
3
2021
57
0.240
Why?
Chemokine CCL3
1
2024
13
0.240
Why?
HMGB1 Protein
1
2024
21
0.240
Why?
Chemokine CXCL12
1
2024
33
0.230
Why?
Bone Resorption
2
2024
302
0.220
Why?
Burkitt Lymphoma
1
2023
14
0.210
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2023
11
0.210
Why?
Gene Dosage
2
2020
74
0.210
Why?
Epigenesis, Genetic
3
2023
372
0.200
Why?
Proto-Oncogene Proteins c-akt
1
2023
156
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
80
0.200
Why?
Drug Resistance, Neoplasm
1
2024
316
0.200
Why?
Neoplasm Proteins
2
2021
320
0.190
Why?
Cell Communication
1
2022
68
0.190
Why?
Mice
8
2024
5687
0.190
Why?
Telomere Homeostasis
1
2021
10
0.190
Why?
Ubiquitination
1
2021
42
0.190
Why?
Polycomb Repressive Complex 2
1
2021
46
0.190
Why?
Chromosome Deletion
2
2023
134
0.180
Why?
Loss of Heterozygosity
2
2018
75
0.180
Why?
Lymphoma, B-Cell
1
2021
49
0.180
Why?
Positron-Emission Tomography
2
2022
292
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Sequence Analysis, DNA
2
2018
226
0.170
Why?
B-Lymphocytes
1
2021
171
0.170
Why?
Cell Cycle
1
2021
226
0.170
Why?
Cell Cycle Proteins
1
2021
161
0.170
Why?
Lymphoma, Follicular
1
2020
21
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Leukemia, Plasma Cell
1
2020
32
0.170
Why?
Cell Line, Tumor
4
2024
1398
0.170
Why?
Gene Regulatory Networks
1
2020
106
0.160
Why?
Genes, myc
1
2019
32
0.160
Why?
Tumor Suppressor Protein p53
2
2017
213
0.150
Why?
Transplantation, Autologous
4
2024
481
0.150
Why?
Mutagenesis
1
2018
58
0.150
Why?
Diffusion Magnetic Resonance Imaging
1
2018
125
0.150
Why?
Genome
1
2018
65
0.150
Why?
Neoplasm, Residual
1
2018
160
0.150
Why?
Homologous Recombination
1
2018
41
0.140
Why?
Female
11
2024
27081
0.140
Why?
Chromosomes, Human, Pair 17
1
2017
34
0.140
Why?
Transcriptome
2
2020
313
0.140
Why?
Survival Rate
4
2021
909
0.140
Why?
Animals
8
2024
13124
0.140
Why?
DNA Repair
1
2018
188
0.130
Why?
Flow Cytometry
1
2018
474
0.130
Why?
DNA Copy Number Variations
3
2022
109
0.120
Why?
Aged
8
2021
9741
0.120
Why?
Remission Induction
3
2021
208
0.120
Why?
Aged, 80 and over
5
2021
3226
0.120
Why?
Genes, Neoplasm
1
2015
27
0.120
Why?
Pattern Recognition, Automated
1
2015
40
0.120
Why?
Cluster Analysis
1
2015
219
0.120
Why?
Male
11
2024
25907
0.120
Why?
Middle Aged
8
2021
12611
0.110
Why?
Follow-Up Studies
4
2021
2242
0.110
Why?
Databases, Protein
1
2013
28
0.100
Why?
Protein Structure, Secondary
1
2013
71
0.100
Why?
Sequence Alignment
1
2013
119
0.100
Why?
Amino Acid Sequence
1
2013
574
0.100
Why?
Chromatin
2
2023
137
0.090
Why?
T-Lymphocytes
2
2024
325
0.090
Why?
Adenocarcinoma
1
2015
397
0.090
Why?
Breast Neoplasms
1
2020
1201
0.090
Why?
Mutation Rate
2
2021
35
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
231
0.090
Why?
Tumor Burden
2
2020
130
0.090
Why?
Alleles
2
2021
256
0.080
Why?
Adult
6
2021
13577
0.080
Why?
Clone Cells
2
2021
70
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
67
0.080
Why?
Histones
2
2021
297
0.080
Why?
Lung Neoplasms
1
2015
601
0.080
Why?
DNA, Neoplasm
2
2020
143
0.080
Why?
DNA Mutational Analysis
2
2020
175
0.080
Why?
Treatment Outcome
4
2020
5283
0.070
Why?
DNA Methylation
2
2023
550
0.070
Why?
Recurrence
2
2021
659
0.070
Why?
Genomic Instability
2
2018
90
0.070
Why?
Risk Factors
3
2021
3724
0.060
Why?
Cell Proliferation
2
2021
985
0.060
Why?
Internet
2
2018
259
0.060
Why?
Killer Cells, Natural
1
2024
106
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
CD8-Positive T-Lymphocytes
1
2024
125
0.050
Why?
Xenograft Model Antitumor Assays
1
2024
212
0.050
Why?
Antibodies
1
2024
153
0.050
Why?
Proteasome Inhibitors
1
2024
104
0.050
Why?
Integrin beta Chains
1
2023
13
0.050
Why?
Integrins
1
2023
30
0.050
Why?
Oxidative Phosphorylation
1
2023
41
0.050
Why?
Cytogenetic Analysis
1
2023
74
0.050
Why?
B-Cell Maturation Antigen
1
2024
99
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cystatin M
1
2022
19
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
92
0.050
Why?
Immunoglobulins
1
2023
81
0.050
Why?
Forkhead Transcription Factors
1
2023
110
0.050
Why?
Phylogeny
1
2022
236
0.050
Why?
Syndecan-1
1
2021
75
0.050
Why?
Spliceosomes
1
2021
10
0.050
Why?
Transcriptional Activation
1
2021
119
0.050
Why?
RNA Splicing
1
2021
38
0.040
Why?
Alternative Splicing
1
2021
53
0.040
Why?
Cyclin D2
1
2020
20
0.040
Why?
Spatio-Temporal Analysis
1
2020
9
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
49
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
29
0.040
Why?
Cyclin D1
1
2020
52
0.040
Why?
Ecosystem
1
2021
65
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
66
0.040
Why?
Phosphoproteins
1
2021
115
0.040
Why?
Single-Cell Analysis
1
2020
63
0.040
Why?
Mice, Transgenic
1
2021
540
0.040
Why?
Cell Differentiation
1
2022
640
0.040
Why?
DNA
1
2023
535
0.040
Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
Why?
Genetic Variation
1
2020
207
0.040
Why?
Genes, Immunoglobulin Heavy Chain
1
2019
12
0.040
Why?
Melphalan
1
2020
178
0.040
Why?
Neoplasm Invasiveness
1
2020
269
0.040
Why?
Osteoclasts
1
2022
427
0.040
Why?
Multivariate Analysis
1
2021
583
0.040
Why?
Osteogenesis
1
2022
356
0.040
Why?
Combined Modality Therapy
1
2021
641
0.040
Why?
Disease Models, Animal
1
2024
1436
0.040
Why?
Maintenance Chemotherapy
1
2019
48
0.040
Why?
Apoptosis
1
2024
1097
0.040
Why?
Cell Survival
1
2020
589
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.040
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.040
Why?
Genome-Wide Association Study
1
2018
163
0.040
Why?
STAT3 Transcription Factor
1
2017
77
0.040
Why?
Information Dissemination
1
2018
80
0.030
Why?
Reproducibility of Results
1
2021
1197
0.030
Why?
Fibroblast Growth Factors
1
2017
45
0.030
Why?
Mitogen-Activated Protein Kinases
1
2017
155
0.030
Why?
Prospective Studies
1
2023
2378
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1372
0.030
Why?
Proportional Hazards Models
1
2018
415
0.030
Why?
Thalidomide
1
2019
378
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Kaplan-Meier Estimate
1
2018
464
0.030
Why?
Genes, p53
1
2016
49
0.030
Why?
Cohort Studies
1
2020
1452
0.030
Why?
Models, Genetic
1
2016
172
0.030
Why?
Antineoplastic Agents
1
2024
1172
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
140
0.030
Why?
Survival Analysis
1
2017
661
0.030
Why?
Stem Cell Transplantation
1
2016
179
0.030
Why?
Dogs
1
2015
186
0.030
Why?
Databases, Genetic
1
2015
88
0.030
Why?
Time Factors
1
2021
2935
0.030
Why?
Sequence Analysis, RNA
1
2015
88
0.030
Why?
Genetic Testing
1
2015
120
0.030
Why?
Longitudinal Studies
1
2016
735
0.030
Why?
Retrospective Studies
1
2024
6263
0.020
Why?
Child
1
2023
6906
0.020
Why?
Ashby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description